Cambridge Cognition (LON:COG) Reaches New 1-Year Low at $43.00

Shares of Cambridge Cognition Holdings Plc (LON:COGGet Free Report) hit a new 52-week low during trading on Wednesday . The company traded as low as GBX 43 ($0.55) and last traded at GBX 46 ($0.59), with a volume of 1216 shares traded. The stock had previously closed at GBX 44.50 ($0.57).

Cambridge Cognition Price Performance

The company has a debt-to-equity ratio of 18.95, a current ratio of 0.45 and a quick ratio of 0.96. The company’s 50-day simple moving average is GBX 50.65 and its 200-day simple moving average is GBX 51.87. The stock has a market capitalization of £15.64 million, a P/E ratio of -445.00 and a beta of 0.80.

Cambridge Cognition Company Profile

(Get Free Report)

Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB digital cognitive assessment platform for drug development by enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval, as well as supports sponsors to enhance recruitment, develop safe and effective treatments, and enhance research and development efficiency.

Recommended Stories

Receive News & Ratings for Cambridge Cognition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambridge Cognition and related companies with MarketBeat.com's FREE daily email newsletter.